Loading…
Synthesis, antimicrobial, and anti-HIV-1 activity of certain 5-(1-adamantyl)-2-substituted thio-1,3,4-oxadiazoles and 5-(1-adamantyl)-3-substituted aminomethyl-1,3,4-oxadiazoline-2-thiones
Derivatives of the above structures were synthesized and tested for their in vitro antimicrobial and anti-HIV-1 activity. The reaction of 5-(1-adamantyl)-1,3,4-oxadiazoline-2-thione 2 with iodoethane, 2-dimethylaminoethyl chloride hydrochloride or 2-piperidinoethyl chloride hydrochloride in ethanoli...
Saved in:
Published in: | Bioorganic & medicinal chemistry 2004-10, Vol.12 (19), p.5107-5113 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Derivatives of the above structures were synthesized and tested for their in vitro antimicrobial and anti-HIV-1 activity.
The reaction of 5-(1-adamantyl)-1,3,4-oxadiazoline-2-thione
2 with iodoethane, 2-dimethylaminoethyl chloride hydrochloride or 2-piperidinoethyl chloride hydrochloride in ethanolic potassium hydroxide yielded the corresponding 5-(1-adamantyl)-2-ethyl or substituted ethylthio-1,3,4-oxadiazoles
3a–
c. Interaction of
2 with formaldehyde solution and primary aromatic amines or 1-substituted piperazines, in ethanol at room temperature yielded the corresponding 5-(1-adamantyl)-3-arylaminomethyl-1,3,4-oxadiazoline-2-thiones
4a–
m or 5-(1-adamantyl)-3-(4-substituted-1-piperazinylmethyl)-1,3,4-oxadiazoline-2-thiones
5a–
h, respectively. All the synthesized compounds were tested for in vitro activities against certain strains of Gram-positive and Gram-negative bacteria and the yeast-like pathogenic fungus
Candida albicans. Compounds
2,
5a, and
5e were found as the most active derivatives, particularly against the Gram-positive bacteria. In addition, the antiviral activity of compounds
2,
4a–
m, and
5a–
h against HIV-1 using the XTT assay was carried out. Compound
2 produced 100%, 43%, and 37% reduction of viral replication at 50, 10, and 2
μg/mL concentrations, respectively. |
---|---|
ISSN: | 0968-0896 1464-3391 |
DOI: | 10.1016/j.bmc.2004.07.033 |